Siemens Healthcare Diagnostics, Inc. Atellica IM 1600 Analyzer - In vitro diagnostic testing of clinical specimens. Product Siemens Material Number (SMN): 11066000 - Product Usage: intended for the qualitative and quantitative analysis of various body fluids, using photometric, turbidimetric, chemiluminescent, and integrated ion selective electrode technology for clinical use. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Atellica IM 1600 Analyzer - In vitro diagnostic testing of clinical specimens. Product Siemens Material Number (SMN): 11066000 - Product Usage: intended for the qualitative and quantitative analysis of various body fluids, using photometric, turbidimetric, chemiluminescent, and integrated ion selective electrode technology for clinical use.
Brand
Siemens Healthcare Diagnostics, Inc.
Lot Codes / Batch Numbers
Software (SW) versions V1.23.2 (SMN 11469032) or lower
Products Sold
Software (SW) versions V1.23.2 (SMN 11469032) or lower
Siemens Healthcare Diagnostics, Inc. is recalling Atellica IM 1600 Analyzer - In vitro diagnostic testing of clinical specimens. Product Siemens Mater due to Multiple issues in Software v1.23.2 and lower-may lead to the reporting of discrepant patient results. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Multiple issues in Software v1.23.2 and lower-may lead to the reporting of discrepant patient results
Recommended Action
Per FDA guidance
Siemens has issued an Urgent Medical Device Correction letter (UMDC ASW21-02.A.US) and Urgent Field Safety Notice, (UFSN ASW21-02.A.OUS) to all affected Customers stating reason for recall, health risk and action to take: Software version 1.24.x correcting the issues will be released when available and all systems will be updated. The following actions must be taken until your system has been updated to software version 1.24 or higher which resolves the issues listed below. Siemens Healthineers will notify you when an updated software version is available. Issue Number 1: Patient sample may be run on analyzer where it was disabled. 1. When reporting results, ensure that the result for the assay that is disabled on one analyzer, came from a system where the assay had not been disabled and all QC results are within the laboratory acceptable range. 2. To check if an assay is enabled or disabled, navigate to Setup/>/Test Definition/>/Assay List/>/CH or IM tab./An assay is/enabled if the box is checked in the column/for an analyzer. 3. The Audit Trail screen (System->Logs->Audit Trail.Log) can be checked to see if an assay had been disabled in the past. Issue Number 2: Bypass mode patient samples may be run. 1. Always ensure that the system covers are properly physically closed and latched. The lock glyph on the System > Status/screen for an analyzer indicates whether the cover is locked or/unlocked. Ensure that there are no yellow unlocked glyphs displayed. 2. Before starting/sample processing,/check/the Operator Event log and ensure that the following error code is not present: 03 600 00 44: A cover is open with the Service Bypass Tools in place. Ensure all operators are clear of moving subassemblies to avoid personal injury or system damage. Corrective Action: Contact the local technical support provider for assistance./ Refer to the online help Alerts section 03 IM Event Troubleshooting if the error code is present. Issue Number
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026